Pitfalls in neuroendocrine tumor diagnosis

par Bajetta, Emilio, Platania, Marco
Publié 2009

Prevention of acute chemotherapy-induced nausea and vomiting: the role of palonosetron

par Bajetta, Emilio, Pusceddu, Sara, Guadalupi, Valentina, Ducceschi, Monika, Celio, Luigi
Publié 2009

Common Diagnostic Challenges in the Histopathologic Diagnosis of Neuroendocrine Lung Tumors: A Case Report

par Valente, Monica, Catena, Laura, Milione, Massimo, Pusceddu, Sara, Formisano, Barbara, Bajetta, Emilio
Publié 2010

Palonosetron plus single-dose dexamethasone for the prevention of nausea and vomiting in women receiving anthracycline/cyclophosphamide-containing chemotherapy: meta-analysis of in...

par Celio, Luigi, Bonizzoni, Erminio, Bajetta, Emilio, Sebastiani, Silvia, Perrone, Tania, Aapro, Matti S.
Publié 2012

Long-Lasting Exceptional Radiological Complete Response after Treatment with Eribulin in a Patient with Triple-Negative Breast Cancer with Liver Involvement

par Dottorini, Lorenzo, Catena, Laura, Sarno, Italo, Di Menna, Giandomenico, Marte, Annamaria, Bajetta, Emilio
Publié dans Oncology (2018)

Everolimus Plus Octreotide Long-Acting Repeatable in Patients With Colorectal Neuroendocrine Tumors: A Subgroup Analysis of the Phase III RADIANT-2 Study

par Castellano, Daniel, Bajetta, Emilio, Panneerselvam, Ashok, Saletan, Stephen, Kocha, Walter, O'Dorisio, Thomas, Anthony, Lowell B., Hobday, Timothy
Publié 2013

Efficacy of octreotide long-acting repeatable in neuroendocrine tumors: RADIANT-2 placebo arm post hoc analysis

par Strosberg, Jonathan R, Yao, James C, Bajetta, Emilio, Aout, Mounir, Bakker, Bert, Hainsworth, John D, Ruszniewski, Philippe B, Van Cutsem, Eric, Öberg, Kjell, Pavel, Marianne E
Publié dans Endocr Relat Cancer (2015)

Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following moderately emetogenic chemotherapy: a randomized, multicenter, pha...

par Celio, Luigi, Frustaci, Sergio, Denaro, Angela, Buonadonna, Angela, Ardizzoia, Antonio, Piazza, Elena, Fabi, Alessandra, Capobianco, Alba Maria, Isa, Luciano, Cavanna, Luigi, Bertolini, Alessandro, Bichisao, Ettore, Bajetta, Emilio
Publié 2010

Circulating Biomarkers in Advanced Colorectal Cancer Patients Randomly Assigned to Three Bevacizumab-Based Regimens

par Martinetti, Antonia, Miceli, Rosalba, Sottotetti, Elisa, Di Bartolomeo, Maria, de Braud, Filippo, Gevorgyan, Arpine, Dotti, Katia Fiorella, Bajetta, Emilio, Campiglio, Manuela, Bianchi, Francesca, Bregni, Giacomo, Pietrantonio, Filippo
Publié 2014

Phase II Study of Everolimus in Patients With Metastatic Colorectal Adenocarcinoma Previously Treated With Bevacizumab-, Fluoropyrimidine-, Oxaliplatin-, and Irinotecan-Based Regim...

par Ng, Kimmie, Tabernero, Josep, Hwang, Jimmy, Bajetta, Emilio, Sharma, Sunil, Del Prete, Salvatore A., Arrowsmith, Edward R., Ryan, David P., Sedova, Michaela, Jin, Jin, Malek, Kamel, Fuchs, Charles S.
Publié 2013

The cost of unresectable stage III or stage IV melanoma in Italy

par Maio Michele, Ascierto Paolo, Testori Alessandro, Ridolfi Ruggero, Bajetta Emilio, Queirolo Paola, Guida Michele, Romanini Antonella, Chiarion-Sileni Vanna, Pigozzo Jacopo, Di Giacomo Anna Maria, Calandriello Mario, Didoni Guido, van Baardewijk Marck, Konto Cyril, Lucioni Carlo
Publié 2012-11-01

The cost of unresectable stage III or stage IV melanoma in Italy

par Maio, Michele, Ascierto, Paolo, Testori, Alessandro, Ridolfi, Ruggero, Bajetta, Emilio, Queirolo, Paola, Guida, Michele, Romanini, Antonella, Chiarion-Sileni, Vanna, Pigozzo, Jacopo, Di Giacomo, Anna Maria, Calandriello, Mario, Didoni, Guido, van Baardewijk, Marck, Konto, Cyril, Lucioni, Carlo
Publié 2012

Clinical experience with ipilimumab 10 mg/kg in patients with melanoma treated at Italian centres as part of a European expanded access programme

par Altomonte, Maresa, Di Giacomo, Anna Maria, Queirolo, Paola, Ascierto, Paolo Antonio, Spagnolo, Francesco, Bajetta, Emilio, Calabrò, Luana, Danielli, Riccardo, de Rosa, Francesco, Maur, Michela, Chiarion-Sileni, Vanna, Ferrucci, Pier Francesco, Giannarelli, Diana, Testori, Alessandro, Ridolfi, Ruggero, Maio, Michele
Publié 2013

A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors

par Pusceddu, Sara, Barretta, Francesco, Trama, Annalisa, Botta, Laura, Milione, Massimo, Buzzoni, Roberto, De Braud, Filippo, Mazzaferro, Vincenzo, Pastorino, Ugo, Seregni, Ettore, Mariani, Luigi, Gatta, Gemma, Di Bartolomeo, Maria, Femia, Daniela, Prinzi, Natalie, Coppa, Jorgelina, Panzuto, Francesco, Antonuzzo, Lorenzo, Bajetta, Emilio, Brizzi, Maria Pia, Campana, Davide, Catena, Laura, Comber, Harry, Dwane, Fiona, Fazio, Nicola, Faggiano, Antongiulio, Giuffrida, Dario, Henau, Kris, Ibrahim, Toni, Marconcini, Riccardo, Massironi, Sara, Žakelj, Maja Primic, Spada, Francesca, Tafuto, Salvatore, Van Eycken, Elizabeth, Van der Zwan, Jan Maaten, Žagar, Tina, Giacomelli, Luca, Miceli, Rosalba, Aroldi, Francesca, Bongiovanni, Alberto, Berardi, Rossana, Brighi, Nicole, Cingarlini, Sara, Cauchi, Carolina, Cavalcoli, Federica, Carnaghi, Carlo, Corti, Francesca, Duro, Marilina, Davì, Maria Vittoria, De Divitiis, Chiara, Ermacora, Paola, La Salvia, Anna, Luppi, Gabriele, Lo Russo, Giuseppe, Nichetti, Federico, Raimondi, Alessandra, Perfetti, Vittorio, Razzore, Paola, Rinzivillo, Maria, Siesling, Sabine, Torchio, Martina, Van Dijk, Boukje, Visser, Otto, Vernieri, Claudio
Publié dans Endocr Relat Cancer (2018)